Profil
Jan Gustaf Zetterberg is currently Chairman at ExThera AB, Zelibra AB, Hepotherm Holding AB, Hepotherm, and Zelfarm AB. The current roles also include Director positions at Thomas Helledays Stift For Medicinsk Forskning, Zedur AB, and Helleday Laboratories AB. Additionally, the current jobs include Legal Counsel at SelectImmune Pharma AB and Head-Legal at Hamlet BioPharma AB. Former positions include Chairman at Oxcia AB, Independent Director at Elicera Therapeutics AB, and VP-Strategy & Assistant General Counsel at AstraZeneca PLC.
Postes actifs de Jan Gustaf Zetterberg
| Sociétés | Poste | Début |
|---|---|---|
| SELECTIMMUNE PHARMA AB (PUBL) | Conseiller Juridique Général | 01/01/2017 |
| HAMLET PHARMA AB (PUBL) | Conseiller Juridique Général | - |
ExThera AB
ExThera AB Pharmaceuticals: MajorHealth Technology Manufactures medical products in both in vitro and in vivo studies | Président | 23/01/2014 |
Zelibra AB | Président | - |
Thomas Helledays Stift For Medicinsk Forskning | Directeur/Membre du Conseil | - |
Hepotherm Holding AB
Hepotherm Holding AB Miscellaneous Commercial ServicesCommercial Services Provides corporate consulting services | Président | - |
Hepotherm | Président | - |
Zelfarm AB | Président | - |
Helleday Laboratories AB | Directeur/Membre du Conseil | - |
| ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Jan Gustaf Zetterberg
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ExThera AB
ExThera AB Pharmaceuticals: MajorHealth Technology Manufactures medical products in both in vitro and in vivo studies | Health Technology |
Zelibra AB | |
Thomas Helledays Stift For Medicinsk Forskning | |
Hamlet BioPharma AB
Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
Zedur AB
Zedur AB Miscellaneous Commercial ServicesCommercial Services Provides legal support services to the life science industry | Commercial Services |
SelectImmune Pharma AB
SelectImmune Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and manufactures immune enhancers to complement antibiotics | Health Technology |
Hepotherm Holding AB
Hepotherm Holding AB Miscellaneous Commercial ServicesCommercial Services Provides corporate consulting services | Commercial Services |
Hepotherm | |
Zelfarm AB | |
Helleday Laboratories AB | |
Oxcia AB | |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
















